Achieve Ebitda vs Cost Of Revenue Analysis

ACHV Stock

USD 4.41 0.08 1.78%

Achieve Life financial indicator trend analysis is way more than just evaluating Achieve Life Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Achieve Life Sciences is a good investment. Please check the relationship between Achieve Life Ebitda and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Achieve Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Ebitda vs Cost Of Revenue

Ebitda vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Achieve Life Sciences Ebitda account and Cost Of Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Achieve Life's Ebitda and Cost Of Revenue is -0.26. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Achieve Life Sciences, assuming nothing else is changed. The correlation between historical values of Achieve Life's Ebitda and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Achieve Life Sciences are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Ebitda i.e., Achieve Life's Ebitda and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

-0.26

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Ebitda

Cost Of Revenue

Cost of Revenue is found on Achieve Life Sciences income statement and represents the costs associated with goods and services Achieve Life provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Achieve Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Achieve Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Achieve Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Enterprise Value is likely to climb to about 87 M in 2024, whereas Selling General Administrative is likely to drop slightly above 10.9 M in 2024.

Achieve Life fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Cash	Cash And Short Term Investments	Common Stock Total Equity	Short Term Investments	Common Stock	Current Deferred Revenue	Net Receivables
Total Assets		-0.18	0.59	0.53	0.91	0.05	-0.57	-0.34	0.6	-0.4	0.33	-0.31	0.21	0.58	0.56	0.57	-0.03	1.0	-0.33	0.56	0.99	-0.41	0.76	-0.41	0.75	0.11
Short Long Term Debt Total	-0.18		-0.02	0.27	-0.46	-0.25	0.59	-0.32	0.09	0.15	0.34	0.81	0.25	0.09	0.16	0.43	-0.19	-0.19	0.95	-0.12	-0.18	0.07	-0.09	0.07	0.02	-0.07
Other Current Liab	0.59	-0.02		0.53	0.46	0.3	-0.3	-0.19	0.52	-0.4	0.03	-0.17	0.03	0.11	0.3	0.48	0.28	0.6	-0.12	0.37	0.67	0.01	0.61	0.01	0.22	-0.12
Total Current Liabilities	0.53	0.27	0.53		0.2	0.23	-0.05	-0.49	0.21	-0.69	-0.07	0.06	-0.11	0.23	0.5	0.84	0.03	0.55	0.11	0.22	0.54	-0.08	0.52	-0.08	0.65	0.24
Total Stockholder Equity	0.91	-0.46	0.46	0.2		0.04	-0.62	-0.15	0.57	-0.26	0.27	-0.5	0.04	0.54	0.42	0.18	-0.04	0.9	-0.56	0.45	0.88	-0.44	0.68	-0.44	0.6	0.05
Property Plant And Equipment Net	0.05	-0.25	0.3	0.23	0.04		0.02	0.03	-0.04	-0.46	-0.14	-0.44	-0.21	0.19	-0.04	0.07	0.79	0.08	-0.31	-0.11	0.07	0.65	0.32	0.65	-0.05	0.66
Net Debt	-0.57	0.59	-0.3	-0.05	-0.62	0.02		0.14	0.0	0.11	0.13	0.31	-0.22	-0.03	-0.31	-0.14	0.06	-0.56	0.53	-0.86	-0.59	0.42	-0.04	0.42	-0.21	0.21
Retained Earnings	-0.34	-0.32	-0.19	-0.49	-0.15	0.03	0.14		-0.1	0.45	-0.08	-0.38	0.0	-0.23	-0.96	-0.47	0.2	-0.35	-0.37	-0.34	-0.32	0.4	-0.09	0.4	-0.25	0.01
Accounts Payable	0.6	0.09	0.52	0.21	0.57	-0.04	0.0	-0.1		-0.25	0.38	-0.18	0.2	0.26	0.25	0.29	0.08	0.6	-0.09	0.04	0.66	-0.07	0.79	-0.07	0.37	-0.18
Non Current Assets Total	-0.4	0.15	-0.4	-0.69	-0.26	-0.46	0.11	0.45	-0.25		0.4	0.25	0.35	-0.17	-0.47	-0.43	-0.39	-0.45	0.28	-0.09	-0.45	-0.2	-0.57	-0.2	-0.33	-0.36
Non Currrent Assets Other	0.33	0.34	0.03	-0.07	0.27	-0.14	0.13	-0.08	0.38	0.4		-0.02	0.62	0.61	0.15	0.26	-0.12	0.3	0.25	-0.01	0.26	-0.15	0.29	-0.15	0.28	0.15
Common Stock Shares Outstanding	-0.31	0.81	-0.17	0.06	-0.5	-0.44	0.31	-0.38	-0.18	0.25	-0.02		0.16	-0.17	0.22	0.2	-0.38	-0.32	0.91	0.11	-0.31	-0.16	-0.46	-0.16	-0.18	-0.32
Non Current Liabilities Total	0.21	0.25	0.03	-0.11	0.04	-0.21	-0.22	0.0	0.2	0.35	0.62	0.16		0.19	0.01	0.43	0.04	0.19	0.2	0.41	0.22	0.01	0.0	0.01	0.03	-0.06
Other Current Assets	0.58	0.09	0.11	0.23	0.54	0.19	-0.03	-0.23	0.26	-0.17	0.61	-0.17	0.19		0.36	0.3	0.22	0.57	-0.06	0.08	0.49	0.0	0.56	0.0	0.43	0.65
Other Stockholder Equity	0.56	0.16	0.3	0.5	0.42	-0.04	-0.31	-0.96	0.25	-0.47	0.15	0.22	0.01	0.36		0.47	-0.21	0.58	0.19	0.45	0.54	-0.51	0.26	-0.51	0.4	0.0
Total Liab	0.57	0.43	0.48	0.84	0.18	0.07	-0.14	-0.47	0.29	-0.43	0.26	0.2	0.43	0.3	0.47		0.03	0.58	0.27	0.43	0.59	-0.08	0.45	-0.08	0.59	0.17
Property Plant And Equipment Gross	-0.03	-0.19	0.28	0.03	-0.04	0.79	0.06	0.2	0.08	-0.39	-0.12	-0.38	0.04	0.22	-0.21	0.03		-0.01	-0.29	-0.1	0.02	0.84	0.3	0.84	-0.35	0.55
Total Current Assets	1.0	-0.19	0.6	0.55	0.9	0.08	-0.56	-0.35	0.6	-0.45	0.3	-0.32	0.19	0.57	0.58	0.58	-0.01		-0.34	0.55	0.99	-0.38	0.77	-0.38	0.75	0.13
Short Term Debt	-0.33	0.95	-0.12	0.11	-0.56	-0.31	0.53	-0.37	-0.09	0.28	0.25	0.91	0.2	-0.06	0.19	0.27	-0.29	-0.34		-0.08	-0.34	-0.03	-0.34	-0.03	-0.15	-0.2
Cash	0.56	-0.12	0.37	0.22	0.45	-0.11	-0.86	-0.34	0.04	-0.09	-0.01	0.11	0.41	0.08	0.45	0.43	-0.1	0.55	-0.08		0.59	-0.38	-0.01	-0.38	0.21	-0.26
Cash And Short Term Investments	0.99	-0.18	0.67	0.54	0.88	0.07	-0.59	-0.32	0.66	-0.45	0.26	-0.31	0.22	0.49	0.54	0.59	0.02	0.99	-0.34	0.59		-0.34	0.77	-0.34	0.7	0.03
Common Stock Total Equity	-0.41	0.07	0.01	-0.08	-0.44	0.65	0.42	0.4	-0.07	-0.2	-0.15	-0.16	0.01	0.0	-0.51	-0.08	0.84	-0.38	-0.03	-0.38	-0.34		0.08	1.0	-0.47	0.5
Short Term Investments	0.76	-0.09	0.61	0.52	0.68	0.32	-0.04	-0.09	0.79	-0.57	0.29	-0.46	0.0	0.56	0.26	0.45	0.3	0.77	-0.34	-0.01	0.77	0.08		0.08	0.62	0.33
Common Stock	-0.41	0.07	0.01	-0.08	-0.44	0.65	0.42	0.4	-0.07	-0.2	-0.15	-0.16	0.01	0.0	-0.51	-0.08	0.84	-0.38	-0.03	-0.38	-0.34	1.0	0.08		-0.47	0.5
Current Deferred Revenue	0.75	0.02	0.22	0.65	0.6	-0.05	-0.21	-0.25	0.37	-0.33	0.28	-0.18	0.03	0.43	0.4	0.59	-0.35	0.75	-0.15	0.21	0.7	-0.47	0.62	-0.47		0.22
Net Receivables	0.11	-0.07	-0.12	0.24	0.05	0.66	0.21	0.01	-0.18	-0.36	0.15	-0.32	-0.06	0.65	0.0	0.17	0.55	0.13	-0.2	-0.26	0.03	0.5	0.33	0.5	0.22

Click cells to compare fundamentals

Achieve Life Account Relationship Matchups

Achieve Life fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	21.1M	40.3M	47.5M	30.0M	19.4M	18.4M
Short Long Term Debt Total	362K	169K	73K	16.2M	16.7M	17.6M
Other Current Liab	1.8M	2.4M	3.6M	3.8M	3.5M	3.3M
Total Current Liabilities	2.9M	2.9M	4.6M	5.5M	20.8M	12.0M
Total Stockholder Equity	18.1M	37.3M	28.0M	8.3M	(1.4M)	(1.4M)
Property Plant And Equipment Net	35K	573K	188K	79K	123K	75.1K
Net Debt	(16.3M)	(35.7M)	(42.9M)	(8.6M)	1.2M	1.2M
Retained Earnings	(45.7M)	(60.4M)	(93.6M)	(135.9M)	(165.8M)	(157.5M)
Accounts Payable	859K	332K	841K	1.7M	618K	587.1K
Non Current Assets Total	3.7M	3.3M	2.9M	5.1M	2.4M	2.2M
Non Currrent Assets Other	168K	187K	237K	2.6M	29.0K	30.4K
Common Stock Shares Outstanding	412.3K	2.7M	8.1M	10.6M	19.8M	20.8M
Liabilities And Stockholders Equity	21.1M	40.3M	47.5M	30.0M	19.4M	18.4M
Non Current Liabilities Total	159K	77K	14.9M	16.1M	6K	5.7K
Other Current Assets	670K	2.2M	1.4M	2.5M	1.3M	1.3M
Other Stockholder Equity	63.7M	97.6M	121.5M	144.1M	164.2M	156.0M
Total Liab	3.0M	3.0M	19.5M	21.7M	20.8M	15.7M
Property Plant And Equipment Gross	386K	188K	366K	123K	66K	62.7K
Total Current Assets	17.4M	37.0M	44.6M	24.8M	17.0M	16.1M
Short Term Debt	203K	184K	138K	16.1M	16.7M	17.6M
Cash	16.7M	35.9M	43.0M	24.8M	15.5M	20.3M
Cash And Short Term Investments	16.7M	35.9M	43.0M	24.8M	15.5M	14.8M
Common Stock Total Equity	18K	41K	76K	87K	78.3K	74.4K
Common Stock	41K	76K	79K	87K	90K	85.5K
Net Receivables	7K	8K	153K	105K	111K	105.5K
Intangible Assets	2.1M	1.9M	1.6M	1.4M	1.2M	1.1M
Inventory	222K	(50K)	(8K)	(2.5M)	(2.9M)	(3.0M)
Net Tangible Assets	14.9M	34.4M	25.4M	5.9M	5.3M	5.0M
Retained Earnings Total Equity	(25.4M)	(45.7M)	(60.4M)	(135.9M)	(122.3M)	(116.2M)
Capital Surpluse	41.2M	63.7M	97.6M	144.1M	129.7M	94.8M
Capital Lease Obligations	362K	169K	73K	127K	69K	65.6K
Property Plant Equipment	57K	42K	64K	127K	114.3K	163.3K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Achieve Stock Analysis

When running Achieve Life's price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC